Sintx Technologies (SINT) Other Non-Current Liabilities (2013 - 2026)
Sintx Technologies' (SINT) quarterly Other Non-Current Liabilities came in at $484000.0 in Q1 2026, up 300.0% year-on-year from $121000.0 in Q1 2025, and down 41.48% quarter-over-quarter from $827000.0 in Q4 2025.
Sintx Technologies (SINT) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Sintx Technologies' Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $484000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 300.0% year-over-year to $484000.0 in Q1 2026; TTM through Mar 2026 was $484000.0, a 300.0% increase from a year earlier, with the FY2025 full-year figure at $827000.0, up 297.6% from the prior year.
- Other Non-Current Liabilities fell to $484000.0 in Q1 2026 per SINT's latest filing, from $827000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $870000.0 in Q3 2025 and bottomed at $2000.0 in Q4 2022.
- The 5-year median for Other Non-Current Liabilities is $155000.0 (2023), against an average of $248812.5.
- Across the five-year window, Other Non-Current Liabilities plunged 99.42% in 2022 and surged 15100.0% in 2023, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $2000.0 in 2022, then jumped by 15100.0% to $304000.0 in 2023, then sank by 31.58% to $208000.0 in 2024, then soared by 297.6% to $827000.0 in 2025, then plunged by 41.48% to $484000.0 in 2026.
- Per Business Quant, the three latest SINT Other Non-Current Liabilities figures stand at $484000.0 (Q1 2026), $827000.0 (Q4 2025), and $870000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 484,000.00 |
| Dec 31, 2025 | 827,000.00 |
| Sep 30, 2025 | 870,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 208,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 304,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 139,000.00 |
| Jun 30, 2022 | 198,000.00 |
| Mar 31, 2022 | 306,000.00 |
| Dec 31, 2021 | 347,000.00 |
| Sep 30, 2021 | 818,000.00 |
| Jun 30, 2021 | 1.30 Mn |
| Mar 31, 2021 | 1.29 Mn |